Literature DB >> 2824563

Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells.

L Schweigerer1, G Neufeld, D Gospodarowicz.   

Abstract

Basic fibroblast growth factor (bFGF) stimulates the proliferation of many cells and it is found in a wide variety of normal or transformed tissues. As demonstrated here, bFGF is also present in cultured human Ewing's sarcoma cells. Unexpectedly, however, bFGF isolated from these cells inhibits their own proliferation, indicating that bFGF can act as an endogenous (autocrine) growth inhibitor for cultured Ewing's sarcoma cells. Since bFGF also inhibits the proliferation of some further tumor cells, but stimulates that of others, it can be considered a bifunctional regulator of tumor cell proliferation. The autocrine growth-inhibitory effect of bFGF in Ewing's sarcoma cells may explain the low mitotic activity of Ewing's sarcomas.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824563      PMCID: PMC442414          DOI: 10.1172/JCI113236

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

2.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

Authors:  R F Tucker; G D Shipley; H L Moses; R W Holley
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

3.  Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor.

Authors:  A Lifshitz; C S Lazar; J E Buss; G N Gill
Journal:  J Cell Physiol       Date:  1983-06       Impact factor: 6.384

4.  Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plastic.

Authors:  I Vlodavsky; G M Lui; D Gospodarowicz
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

5.  Round cell tumors in childhood: the application of newer techniques to the differential diagnosis.

Authors:  T J Triche
Journal:  Perspect Pediatr Pathol       Date:  1982

6.  Antibodies specific for alpha-N-acetyl-beta-endorphins: radioimmunoassays and detection of acetylated beta-endorphins in pituitary extracts.

Authors:  E Weber; C J Evans; J K Chang; J D Barchas
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

7.  High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium.

Authors:  D Gospodarowicz; G M Lui; R Gonzalez
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

8.  Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor.

Authors:  D Gospodarowicz; J Cheng; G M Lui; A Baird; P Böhlent
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Sarcomas of bone in childhood: pathologic aspects.

Authors:  J M Kissane; F B Askin; M E Nesbit; T J Vietti; E O Burgert; A Cangir; E A Gehan; C A Perez; D J Pritchard; M Tefft
Journal:  Natl Cancer Inst Monogr       Date:  1981-04

10.  Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth.

Authors:  L Schweigerer; G Neufeld; J Friedman; J A Abraham; J C Fiddes; D Gospodarowicz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

View more
  11 in total

Review 1.  Angiogenesis and angiogenesis inhibitors in paediatric diseases.

Authors:  L Schweigerer; T Fotsis
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

Review 2.  Growth inhibitors: molecular diversity and roles in cell proliferation.

Authors:  K Miyazaki; T Horio
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

3.  Phytic acid stimulates the growth of a human rhabdomyosarcoma.

Authors:  G S Germain; P J Houghton
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-09       Impact factor: 2.416

Review 4.  Basic fibroblast growth factor and its relation to angiogenesis in normal and neoplastic tissue.

Authors:  L Schweigerer
Journal:  Klin Wochenschr       Date:  1988-04-15

Review 5.  Antiangiogenesis as a novel therapeutic concept in pediatric oncology.

Authors:  L Schweigerer
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

6.  Primitive neuroectodermal tumor cell lines derived from a metastatic pediatric tumor.

Authors:  M Furue; T Okamoto; M Ikeda; Y Tanaka; Y Sasaki; K Nishihira; J D Sato
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-12       Impact factor: 2.416

7.  Expression of estrogen receptor α and growth factors in human prolactinoma and its correlation with clinical features and gender.

Authors:  H Lv; C Li; S Gui; Y Zhang
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

8.  Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity.

Authors:  R G de Veas; L Schweigerer; M A Medina
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 9.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

10.  PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death.

Authors:  M Hotfilder; P Sondermann; A Senss; F van Valen; H Jürgens; J Vormoor
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.